Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
- PMID: 37009482
- PMCID: PMC10061106
- DOI: 10.3389/fcell.2023.1179559
Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
Abstract
[This corrects the article DOI: 10.3389/fcell.2021.743908.].
Keywords: ESPAC; clinical trials; molecular subtypes; next generation sequencing; precision medicine; structural variants; transcriptomes.
Copyright © 2023 Zhou, Hu, Bailey, Springfeld, Roth, Kurilov, Brors, Gress, Buchholz, An, Wei, Peccerella, Büchler, Hackert and Neoptolemos.
Erratum for
-
Clinical Impact of Molecular Subtyping of Pancreatic Cancer.Front Cell Dev Biol. 2021 Nov 5;9:743908. doi: 10.3389/fcell.2021.743908. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805152 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources